| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.00▲ | 7.03▼ | 7.05▼ | 7.00▲ | 6.49▲ |
| MA10 | 7.00▲ | 7.06▼ | 7.13▼ | 6.89▲ | 5.57▲ |
| MA20 | 7.01▲ | 7.15▼ | 7.12▼ | 6.41▲ | 5.27▲ |
| MA50 | 7.05▼ | 7.07▼ | 7.00▲ | 5.49▲ | 4.81▲ |
| MA100 | 7.11▼ | 6.99▲ | 6.78▲ | 5.13▲ | 4.88▲ |
| MA200 | 7.13▼ | 6.68▲ | 5.94▲ | 4.82▲ | 6.25▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.021▼ | -0.030▼ | 0.021▲ | 0.244▲ |
| RSI | 52.225▲ | 44.025▼ | 47.551▼ | 65.438▲ | 72.860▲ |
| STOCH | 65.100 | 43.188 | 29.825 | 70.564 | 82.238▲ |
| WILL %R | 0.000▲ | -68.182 | -75.439▼ | -29.916 | -13.734▲ |
| CCI | 131.624▲ | -71.644 | -78.548 | 80.075 | 152.324▲ |
|
Thursday, November 20, 2025 05:59 AM
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting ...
|
|
Sunday, November 16, 2025 04:00 PM
Fintel reports that on November 19, 2025, HC Wainwright & Co. reiterated coverage of Vanda Pharmaceuticals (NasdaqGM:VNDA) with a Buy recommendation. As of November 17, 2025, the average one-year ...
|
|
Thursday, October 30, 2025 05:13 PM
Fintel reports that on October 30, 2025, Cantor Fitzgerald maintained coverage of Vanda Pharmaceuticals (NasdaqGM:VNDA) with a Overweight recommendation. As of October 30, 2025, the average one-year ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/12/25 | 7.09 | 7.135 | 6.89 | 7.03 | 1,465,137 |
| 29/12/25 | 7.21 | 7.4694 | 6.94 | 7.20 | 2,475,641 |
| 26/12/25 | 7.15 | 7.2501 | 6.915 | 7.04 | 1,368,407 |
| 24/12/25 | 6.83 | 6.94 | 6.75 | 6.91 | 515,842 |
| 23/12/25 | 7.03 | 7.18 | 6.785 | 6.84 | 1,526,632 |
| 22/12/25 | 6.88 | 7.20 | 6.70 | 7.03 | 1,243,901 |
| 19/12/25 | 6.71 | 6.94 | 6.69 | 6.75 | 1,484,139 |
| 18/12/25 | 6.82 | 7.05 | 6.58 | 6.67 | 1,870,753 |
| 17/12/25 | 6.65 | 7.035 | 6.58 | 6.82 | 1,347,811 |
| 16/12/25 | 6.65 | 6.90 | 6.50 | 6.65 | 1,322,047 |
|
|
||||
|
|
||||
|
|